Kathleen D. Scott - Net Worth and Insider Trading

Kathleen D. Scott Net Worth

The estimated net worth of Kathleen D. Scott is at least $142,417 dollars as of 2024-12-27. Kathleen D. Scott is the CFO of ARS Pharmaceuticals Inc and owns about 13,199 shares of ARS Pharmaceuticals Inc (SPRY) stock worth over $142,417. Details can be seen in Kathleen D. Scott's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kathleen D. Scott has not made any transactions after 2024-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kathleen D. Scott

To

Kathleen D. Scott Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kathleen D. Scott owns 5 companies in total, including Histogen Inc (HSTOQ) , Dermata Therapeutics Inc (DRMA) , and Silverback Therapeutics Inc (SBTX) among others .

Click here to see the complete history of Kathleen D. Scott’s form 4 insider trades.

Insider Ownership Summary of Kathleen D. Scott

Ticker Comapny Transaction Date Type of Owner
HSTOQ Histogen Inc 2019-11-18 director
DRMA Dermata Therapeutics Inc 2021-08-12 director
SBTX Silverback Therapeutics Inc 2022-11-08 Chief Financial Officer
LIMIT LIMIT 2024-10-16 Chief Financial Officer
LIMIT LIMIT 2023-09-29 director

Kathleen D. Scott Latest Holdings Summary

Kathleen D. Scott currently owns a total of 1 stock. Kathleen D. Scott owns 13,199 shares of ARS Pharmaceuticals Inc (SPRY) as of October 16, 2024, with a value of $142,417.

Latest Holdings of Kathleen D. Scott

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SPRY ARS Pharmaceuticals Inc 2024-10-16 13,199 10.79 142,417

Holding Weightings of Kathleen D. Scott


Kathleen D. Scott Form 4 Trading Tracker

According to the SEC Form 4 filings, Kathleen D. Scott has made a total of 3 transactions in ARS Pharmaceuticals Inc (SPRY) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in ARS Pharmaceuticals Inc is the sale of 12,500 shares on October 16, 2024, which brought Kathleen D. Scott around $200,000.

Insider Trading History of Kathleen D. Scott

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kathleen D. Scott Trading Performance

GuruFocus tracks the stock performance after each of Kathleen D. Scott's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kathleen D. Scott is 50.17%. GuruFocus also compares Kathleen D. Scott's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kathleen D. Scott within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kathleen D. Scott's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kathleen D. Scott

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 40.73 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 43.47 LIMIT LIMIT LIMIT LIMIT LIMIT

Kathleen D. Scott Ownership Network

Ownership Network List of Kathleen D. Scott

No Data

Ownership Network Relation of Kathleen D. Scott

Insider Network Chart

Kathleen D. Scott Owned Company Details

What does Histogen Inc do?

Who are the key executives at Histogen Inc?

Kathleen D. Scott is the director of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .

Histogen Inc (HSTOQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Histogen Inc (HSTOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Histogen Inc Insider Transactions

No Available Data

Kathleen D. Scott Mailing Address

Above is the net worth, insider trading, and ownership report for Kathleen D. Scott. You might contact Kathleen D. Scott via mailing address: C/o Conatus Pharmaceuticals Inc., 16745 West Bernardo Drive, Suite 200, San Diego Ca 92127.

Discussions on Kathleen D. Scott

No discussions yet.